PUBLISHER: IMARC | PRODUCT CODE: 1518556
PUBLISHER: IMARC | PRODUCT CODE: 1518556
The global breast imaging market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.8 Billion by 2032, exhibiting a growth rate (CAGR) of 7.5% during 2024-2032.
Breast imaging refers to the radiological technique of diagnosing breast cancer in both males and females. It involves a range of equipment to screen, detect and determine the location of the tumor and other breast-related infections, lesions and cysts. It also entails various procedures such as mammography, breast biopsy, ultrasound, tactile imaging and Magnetic Resonance Imaging (MRI). The aim of conducting these procedures is to detect the disease at its earliest and most treatable stage. Procedures such as mammography produce digital images in which the brightness, darkness and contrast can be altered as per the requirement, thus making the differentiation between malignant and benign cells simpler. These procedures are considered safe, are non-invasive and cause minimum discomfort to the patient.
The increasing prevalence of breast cancer, along with the rising awareness of the early detection of the disease, is among the key factors driving the growth of the market. Furthermore, the growing geriatric population, which is more susceptible to such ailments, are also contributing to the increased adoption rate of breast imaging procedures. Various technological advancements in the imaging equipment have enabled improved diagnosis of dense breast tissues. Patients are increasingly opting for digital mammography systems that offer high detection rates in comparison to traditionally used analog devices. Additionally, various organizations and healthcare centers are conducting cancer awareness campaigns to educate individuals about breast health and cancer diagnostic measures. Moreover, technological innovations such as the introduction of breast tomosynthesis or 3D mammography, rising healthcare expenditure, growing disposable income, and government initiatives to improve cancer screening and diagnosis are also driving the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast imaging market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on technology and end-user.
Ionizing Breast Imaging
Mammography
Positron Emission Tomography-Computed Tomography
Molecular Breast Imaging
Positron Emission Mammography
Cone-Beam Computed Tomography
Non-Ionizing Breast Imaging
Breast Ultrasound
Breast MRI
Automated Whole-Breast Ultrasound
Breast Thermography
Electric Impedance Tomography
Optical Imaging
Hospitals
Diagnostic Imaging Centers
Ambulatory Surgical Centers
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Allengers Medical Systems Limited, Aurora Health Care Inc. (Schoen Clinic), Canon Inc., Carestream Health Inc. (Onex Corporation), Delphinus Medical Technologies, Dilon Technologies Inc., Fujifilm Holdings Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips N.V., Micrima Limited, Planmed Oy, Siemens Healthineers AG (Cerner Corporation), Toshiba Corporation, etc.